This year’s Bradley County Relay For Life was billed as a festival of hope, and those hopes are now for this fun and successful event to continue bringing in more
As Texas health care organizations, providers, payors, and vendors increasingly adopt and rely on advanced technology to perform various tasks, certain technologies will likely be subject to increased regulatory oversight.
On February 23, 2024, the FDA approved Alvotech and Teva's Simlandi® (adalimumab-ryvk) as biosimilar to and interchangeable with AbbVie's Humira® (adalimumab). Simlandi® is the tenth Humira.